Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and SharmaCapecchi, Pier Leopoldo ; Lazzerini, Pietro EneaAnnals of the rheumatic diseases, 2022-11, Vol.81 (11), p.e214-e214 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and SharmaPotere, Nicola ; Di Nisio, Marcello ; Cibelli, Donatella ; Scurti, Rosa ; Frattari, Antonella ; Porreca, Ettore ; Abbate, Antonio ; Parruti, GiustinoAnnals of the rheumatic diseases, 2022-11, Vol.81 (11), p.e215-e215 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Response to: ‘Differentiating disease activity from damage in systemic sclerosis: it’s still early days!’ by Jain and SharmaNikpour, MandanaAnnals of the rheumatic diseases, 2020-08, Vol.79 (8), p.e99-e99 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Professor Inder Sen Jain: Master and CommanderGupta, Amod ; Sen, Mrittika ; Jain, Sandeep ; Honavar, SantoshIndian journal of ophthalmology, 2022-08, Vol.70 (8), p.2781-2783 [Periódico revisado por pares]Mumbai: Wolters Kluwer India Pvt. LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
From the Editorial Board: Sachin H. Jain, MD, MBAJain, Sachin HThe American journal of managed care, 2021-01, Vol.27 (1) [Periódico revisado por pares]Jamesburg: MultiMedia Healthcare IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Jain point laparoscopic entry in contraindications of Palmers pointJain, Nutan ; Srivastava, Sakshi ; Bayya, Sri Lakshmi Prasanna ; Jain, VandanaFrontiers in surgery, 2022-11, Vol.9, p.928081-928081 [Periódico revisado por pares]Frontiers Media S.ATexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et alStouten, Veerle ; Westhovens, René ; Pazmino, Sofia ; De Cock, Diederik ; Van der Elst, Kristien ; Joly, Johan ; Bertrand, Delphine ; Verschueren, PatrickAnnals of the rheumatic diseases, 2023-07, Vol.82 (7), p.e163-e163 [Periódico revisado por pares]England: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Dr. Budhendra Kumar Jain - Giving sight to changing lives: The journey of a pure soulSen, Alok ; Jain, Elesh ; Maniar, Ranjith ; Kuyyadiyil, SubeeshIndian journal of ophthalmology, 2023-02, Vol.71 (2), p.327-329 [Periódico revisado por pares]India: Wolters Kluwer India Pvt. LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial DysfunctionAchari, Arunkumar E ; Jain, Sushil KInternational journal of molecular sciences, 2017-06, Vol.18 (6), p.1321 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Response to: ‘MYCYC, unravelling the long road ahead in ANCA-associated vasculitis’ by Jain et alHarper, Lorraine ; Jones, Rachel BAnnals of the rheumatic diseases, 2020-05, Vol.79 (5), p.e58-e58 [Periódico revisado por pares]England: BMJ Publishing Group LTDTexto completo disponível |